![](/img/cover-not-exists.png)
Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): a randomised, double-blind, phase 3 trial
Ramalingam, Suresh S, Jänne, Pasi A, Mok, Tony, O'Byrne, Kenneth, Boyer, Michael J, Von Pawel, Joachim, Pluzanski, Adam, Shtivelband, Mikhail, Docampo, Lara Iglesias, Bennouna, Jaafar, Zhang, Hui, LiaVolume:
15
Language:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(14)70452-8
Date:
November, 2014
File:
PDF, 523 KB
english, 2014